Role of E2F in cell cycle control and cancer
- PMID: 9556498
- DOI: 10.2741/a291
Role of E2F in cell cycle control and cancer
Abstract
E2F transcription factors regulate the expression of a number of genes important in cell proliferation, particularly those involved in progression through G1 and into the S-phase of the cell cycle. The activity of E2F factors is regulated through association with the retinoblastoma tumor suppressor protein (Rb) and the other pocket proteins, p107 and p130. Binding of Rb, p107 or p130 converts E2F factors from transcriptional activators to transcriptional repressors. The interplay among G1 cyclins (D-type cyclins and cyclin E), cyclin-dependent kinases (cdk4, 6, and 2), cdk inhibitors, and protein phosphatases determines the phosphorylation state of the pocket proteins which in turn regulates the ability of the pocket proteins to complex with E2F. E2F activity is further regulated through direct interactions with other factors, such cyclin A, Sp1, p53 and the ubiquitin-proteasome pathway. Deregulated expression of E2F family member genes has been shown to induce both inappropriate S phase entry and apoptosis. An important role for E2F in the development of cancer is suggested by the finding that in most human neoplasias, genetic or epigenetic alterations occur that ultimately result in the deregulation of E2F-dependent transcription. This review will highlight recent findings on the specific roles of the individual E2F species in regulating transcription, proliferation and apoptosis, and discuss the growing link between E2F and cancer.
Similar articles
-
Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.Cell Growth Differ. 1995 Oct;6(10):1287-98. Cell Growth Differ. 1995. PMID: 8845306
-
Cell cycle-specific association of E2F with the p130 E1A-binding protein.Genes Dev. 1993 Dec;7(12A):2392-404. doi: 10.1101/gad.7.12a.2392. Genes Dev. 1993. PMID: 8253385
-
Regulation of the retinoblastoma-E2F pathway by the ubiquitin-proteasome system.Biochim Biophys Acta. 2015 Oct;1849(10):1289-97. doi: 10.1016/j.bbagrm.2015.08.008. Epub 2015 Aug 28. Biochim Biophys Acta. 2015. PMID: 26319102 Review.
-
A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.Cell Growth Differ. 1996 Aug;7(8):979-88. Cell Growth Differ. 1996. PMID: 8853893
-
Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.Crit Rev Biochem Mol Biol. 1996 Jun;31(3):237-71. doi: 10.3109/10409239609106585. Crit Rev Biochem Mol Biol. 1996. PMID: 8817077 Review.
Cited by
-
CpG methylation as a mechanism for the regulation of E2F activity.Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6481-6. doi: 10.1073/pnas.100340697. Proc Natl Acad Sci U S A. 2000. PMID: 10823896 Free PMC article.
-
Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma.Transl Lung Cancer Res. 2023 Jul 31;12(7):1517-1538. doi: 10.21037/tlcr-23-306. Epub 2023 Jul 19. Transl Lung Cancer Res. 2023. PMID: 37577299 Free PMC article.
-
Transcription factor E4F1 as a regulator of cell life and disease progression.Sci Adv. 2023 Sep 29;9(39):eadh1991. doi: 10.1126/sciadv.adh1991. Epub 2023 Sep 29. Sci Adv. 2023. PMID: 37774036 Free PMC article. Review.
-
Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis.Theranostics. 2020 Mar 4;10(9):3952-3966. doi: 10.7150/thno.39578. eCollection 2020. Theranostics. 2020. PMID: 32226531 Free PMC article.
-
Flipping the switch from g1 to s phase with e3 ubiquitin ligases.Genes Cancer. 2012 Nov;3(11-12):634-48. doi: 10.1177/1947601912473307. Genes Cancer. 2012. PMID: 23634252 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous